MoonBiotech completed ¥300 million C+ financing, and continued to promote the industrialization of more biological innovation

MoonBiotech announced that it has recently completed a C+ financing of 300 million yuan, which is exclusively invested by SDIC. This round of financing is also MoonBiotech after the C round of financing introduced the State Investment Venture Fund, once again won the support of the national team fund. The new round of funds will be mainly used to promote the large-scale production and commercialization of the company's more biological innovative products, as well as the expansion of its own commercial microbial strain bank and component bank and the further improvement of the biological manufacturing technology platform.

MoonBiotech is a platform biotechnology company focusing on microbial discovery and biological manufacturing. It has built a complete industrial technology system from discovery, screening, transformation to application of microorganisms, and has established the world's largest microbial strain bank and gene element bank with the highest biodiversity, preserving more than 270,000 microbial strains with independent intellectual property rights. Relying on high-specification strain resources, in-depth microbiome research and data mining, as well as leading synthetic biology technology platform, the company efficiently develops and provides first-class bio-based products and solutions for bio-agriculture, biomedicine, microbial protein and other subsectors.